PIK3CD and prostate cancer: Specific splice variants of PIK3CD, TSC2, and RASGRP2 are associated with a more aggressive oncogenic phenotype in AA prostate cancer cells, which has been hypothesized as an underlying mechanism for prostate cancer health disparities between AA and EA men [122].